EP3784663
Setin 4-amínóísóindólín-1,3-díón-efnasambönd og notkun þeirra við meðhöndlun á eitilæxli
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.4.2019EP published:
12.7.2023EP application number:
19726225.6
EP translation filed:
3.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
21.4.2039Expiry date:
21.4.2026Next due date:
30.4.2026
Title in English:
SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND THEIR USE FOR TREATING LYMPHOMALanguage of the patent:
English
Timeline
Today
22.4.2019EP application
12.7.2023EP Publication
3.10.2023Translation submitted
15.11.2023Registration published
21.4.2026Expires
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, Summit, NJ 07901, US
Inventor
Name:
ALEXANDER, Matthew, D.Address:
San Diego, CA 92121, US
Name:
CARRANCIO, SorayaAddress:
San Diego, CA 92121, US
Name:
CORREA, Matthew, D.Address:
San Diego, CA 92121, US
Name:
GRANT, Virginia Heather, SharronAddress:
San Diego, CA 92121, US
Name:
HANSEN, JoshuaAddress:
San Diego, CA 92121, US
Name:
HARRIS, Roy, L.Address:
San Diego, CA 92121, US
Name:
HUANG, DehuaAddress:
San Diego, CA 92121, US
Name:
KERCHER, Timothy, S.Address:
San Diego, CA 92121, US
Name:
LOPEZ-GIRONA, AntoniaAddress:
San Diego, CA 92121, US
Name:
NAGY, Mark, A.Address:
San Diego, CA 92121, US
Name:
PLANTEVIN-KRENITSKY, VeroniqueAddress:
San Diego, CA 92121, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201862661525 PDate:
23.4.2018Country:
US
Classification
Categories:
C07D 401/14, C07D 491/08, C07D 401/04, C07D 417/14, C07D 491/10, A61P 35/00, A61K 31/454
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 7.3.2024
Expires: 21.4.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 18.3.2025
Expires: 21.4.2026
Payer: Árnason Faktor ehf.